Creative Historical Balance Sheet

CELZ Stock

USD 2.27 0.06 2.71%

Trend analysis of Creative Medical Technology balance sheet accounts such as Total Current Liabilities of 311.3 K, Total Stockholder Equity of 6.7 M or Accounts Payable of 366.7 K provides information on Creative Medical's total assets, liabilities, and equity, which is the actual value of Creative Medical Tec to its prevalent stockholders. By breaking down trends over time using Creative Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Creative Medical Tec latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Creative Medical Tec is a good buy for the upcoming year.

Creative Medical Inventory

2,084.3

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Creative Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Creative Medical Tec at a specified time, usually calculated after every quarter, six months, or one year. Creative Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Creative Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Creative currently owns. An asset can also be divided into two categories, current and non-current.

Creative Medical Balance Sheet Chart

At this time, Creative Medical's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to 3,101 in 2025, whereas Total Current Liabilities is likely to drop slightly above 311.3 K in 2025.

Total Assets Total Current Liabilities Accounts Payable Common Stock Shares Outstanding

Total Assets

Total assets refers to the total amount of Creative Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Creative Medical Tec books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Creative Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Creative Medical Technology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Creative Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Creative Medical Tec are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Creative Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Creative Medical Tec current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	3.3M	371.4K	327.6K	311.3K
Total Assets	19.2M	10.7M	6.7M	7.0M

Total Current Liabilities Total Assets

Creative Medical balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Debt	Cash	Cash And Short Term Investments	Other Current Assets	Short Long Term Debt Total	Short Term Debt	Other Current Liab	Current Deferred Revenue	Net Tangible Assets	Other Liab	Non Current Assets Total	Long Term Debt	Short Long Term Debt	Intangible Assets
Total Assets		-0.12	0.57	-0.71	0.83	-0.78	0.74	0.64	0.86	-0.12	1.0	-0.24	-0.95	0.95	1.0	0.84	-0.4	-0.39	-0.17	-0.2	0.59	0.54	0.61	-0.56	0.55	0.61
Total Current Liabilities	-0.12		-0.88	-0.38	0.05	0.16	-0.16	0.33	-0.02	1.0	-0.14	0.66	0.15	-0.12	-0.14	-0.15	0.61	0.62	1.0	0.83	-0.82	0.34	0.51	-0.34	0.36	0.51
Total Stockholder Equity	0.57	-0.88		-0.02	0.35	-0.51	0.49	0.03	0.43	-0.88	0.59	-0.66	-0.58	0.55	0.59	0.52	-0.7	-0.69	-0.91	-0.78	0.96	-0.03	-0.13	0.02	-0.03	-0.13
Retained Earnings	-0.71	-0.38	-0.02		-0.45	0.76	-0.81	-0.41	-0.91	-0.38	-0.68	-0.13	0.59	-0.61	-0.68	-0.71	0.01	0.0	-0.35	-0.25	-0.2	-0.78	-0.94	0.8	-0.83	-0.94
Accounts Payable	0.83	0.05	0.35	-0.45		-0.53	0.4	0.9	0.54	0.05	0.83	-0.04	-0.88	0.89	0.83	0.66	-0.12	-0.12	-0.03	-0.01	0.28	0.42	0.41	-0.43	0.42	0.41
Net Receivables	-0.78	0.16	-0.51	0.76	-0.53		-0.97	-0.31	-0.89	0.16	-0.78	0.26	0.66	-0.66	-0.77	-0.98	0.41	0.4	0.19	0.22	-0.65	-0.49	-0.54	0.51	-0.51	-0.54
Common Stock Shares Outstanding	0.74	-0.16	0.49	-0.81	0.4	-0.97		0.17	0.93	-0.17	0.73	-0.26	-0.62	0.62	0.72	0.91	-0.42	-0.42	-0.19	-0.21	0.67	0.51	0.6	-0.55	0.55	0.6
Non Current Liabilities Total	0.64	0.33	0.03	-0.41	0.9	-0.31	0.17		0.37	0.33	0.64	0.03	-0.69	0.71	0.64	0.44	0.19	0.19	0.25	0.28	-0.05	0.41	0.49	-0.41	0.48	0.49
Other Stockholder Equity	0.86	-0.02	0.43	-0.91	0.54	-0.89	0.93	0.37		-0.02	0.85	-0.15	-0.76	0.77	0.84	0.86	-0.29	-0.28	-0.06	-0.09	0.58	0.68	0.79	-0.71	0.73	0.79
Total Liab	-0.12	1.0	-0.88	-0.38	0.05	0.16	-0.17	0.33	-0.02		-0.14	0.66	0.15	-0.12	-0.14	-0.15	0.61	0.62	1.0	0.83	-0.82	0.34	0.51	-0.34	0.36	0.51
Total Current Assets	1.0	-0.14	0.59	-0.68	0.83	-0.78	0.73	0.64	0.85	-0.14		-0.25	-0.96	0.95	1.0	0.84	-0.42	-0.41	-0.2	-0.22	0.6	0.51	0.59	-0.53	0.53	0.58
Common Stock	-0.24	0.66	-0.66	-0.13	-0.04	0.26	-0.26	0.03	-0.15	0.66	-0.25		0.26	-0.23	-0.25	-0.25	0.6	0.6	0.66	0.48	-0.64	0.32	0.14	-0.32	0.24	0.14
Net Debt	-0.95	0.15	-0.58	0.59	-0.88	0.66	-0.62	-0.69	-0.76	0.15	-0.96	0.26		-1.0	-0.96	-0.73	0.43	0.43	0.21	0.25	-0.57	-0.44	-0.52	0.45	-0.44	-0.52
Cash	0.95	-0.12	0.55	-0.61	0.89	-0.66	0.62	0.71	0.77	-0.12	0.95	-0.23	-1.0		0.96	0.73	-0.38	-0.38	-0.18	-0.2	0.55	0.47	0.55	-0.49	0.48	0.55
Cash And Short Term Investments	1.0	-0.14	0.59	-0.68	0.83	-0.77	0.72	0.64	0.84	-0.14	1.0	-0.25	-0.96	0.96		0.84	-0.42	-0.41	-0.2	-0.22	0.6	0.51	0.59	-0.53	0.52	0.58
Other Current Assets	0.84	-0.15	0.52	-0.71	0.66	-0.98	0.91	0.44	0.86	-0.15	0.84	-0.25	-0.73	0.73	0.84		-0.4	-0.39	-0.19	-0.21	0.63	0.46	0.51	-0.49	0.48	0.5
Short Long Term Debt Total	-0.4	0.61	-0.7	0.01	-0.12	0.41	-0.42	0.19	-0.29	0.61	-0.42	0.6	0.43	-0.38	-0.42	-0.4		1.0	0.59	0.8	-0.71	0.37	0.19	-0.37	0.41	0.19
Short Term Debt	-0.39	0.62	-0.69	0.0	-0.12	0.4	-0.42	0.19	-0.28	0.62	-0.41	0.6	0.43	-0.38	-0.41	-0.39	1.0		0.59	0.8	-0.7	0.39	0.2	-0.38	0.42	0.2
Other Current Liab	-0.17	1.0	-0.91	-0.35	-0.03	0.19	-0.19	0.25	-0.06	1.0	-0.2	0.66	0.21	-0.18	-0.2	-0.19	0.59	0.59		0.81	-0.84	0.29	0.48	-0.29	0.31	0.48
Current Deferred Revenue	-0.2	0.83	-0.78	-0.25	-0.01	0.22	-0.21	0.28	-0.09	0.83	-0.22	0.48	0.25	-0.2	-0.22	-0.21	0.8	0.8	0.81		-0.74	0.47	0.46	-0.47	0.46	0.46
Net Tangible Assets	0.59	-0.82	0.96	-0.2	0.28	-0.65	0.67	-0.05	0.58	-0.82	0.6	-0.64	-0.57	0.55	0.6	0.63	-0.71	-0.7	-0.84	-0.74		0.07	0.01	-0.09	0.08	0.0
Other Liab	0.54	0.34	-0.03	-0.78	0.42	-0.49	0.51	0.41	0.68	0.34	0.51	0.32	-0.44	0.47	0.51	0.46	0.37	0.39	0.29	0.47	0.07		0.82	-0.97	0.95	0.82
Non Current Assets Total	0.61	0.51	-0.13	-0.94	0.41	-0.54	0.6	0.49	0.79	0.51	0.59	0.14	-0.52	0.55	0.59	0.51	0.19	0.2	0.48	0.46	0.01	0.82		-0.83	0.89	1.0
Long Term Debt	-0.56	-0.34	0.02	0.8	-0.43	0.51	-0.55	-0.41	-0.71	-0.34	-0.53	-0.32	0.45	-0.49	-0.53	-0.49	-0.37	-0.38	-0.29	-0.47	-0.09	-0.97	-0.83		-0.95	-0.83
Short Long Term Debt	0.55	0.36	-0.03	-0.83	0.42	-0.51	0.55	0.48	0.73	0.36	0.53	0.24	-0.44	0.48	0.52	0.48	0.41	0.42	0.31	0.46	0.08	0.95	0.89	-0.95		0.89
Intangible Assets	0.61	0.51	-0.13	-0.94	0.41	-0.54	0.6	0.49	0.79	0.51	0.58	0.14	-0.52	0.55	0.58	0.5	0.19	0.2	0.48	0.46	0.0	0.82	1.0	-0.83	0.89

Click cells to compare fundamentals

Creative Medical Account Relationship Matchups

Creative Medical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	717.8K	11.3M	19.2M	10.7M	6.7M	7.0M
Total Current Liabilities	40.5M	1.1M	3.3M	371.4K	327.6K	311.3K
Total Stockholder Equity	(39.8M)	10.2M	15.9M	10.3M	6.3M	6.7M
Retained Earnings	(61.9M)	(43.7M)	(53.8M)	(59.1M)	(64.6M)	(61.4M)
Accounts Payable	350.9K	761.9K	3.3M	317.3K	273.5K	366.7K
Net Receivables	5.6K	0.0	2.5K	(10.1M)	(9.1M)	(8.6M)
Common Stock Shares Outstanding	57.9K	324.9K	1.1M	1.4M	1.5M	1.6M
Liabilities And Stockholders Equity	717.8K	11.3M	19.2M	10.7M	6.7M	7.0M
Other Stockholder Equity	21.3M	53.9M	69.7M	69.4M	70.9M	74.5M
Total Liab	40.5M	1.1M	3.3M	371.4K	327.6K	311.3K
Total Current Assets	98.0K	10.7M	18.7M	10.3M	6.1M	6.4M
Common Stock	768.5K	6.3K	14.1K	1.4K	1.7K	1.7K
Net Debt	690.7K	(10.7M)	(18.4M)	(3.5M)	(5.9M)	(5.6M)
Cash	98.0K	10.7M	18.4M	3.5M	5.9M	6.2M
Cash And Short Term Investments	98.0K	10.7M	18.4M	10.0M	5.9M	6.2M
Short Long Term Debt Total	682.1K	1.1M	788.7K	14.2K	16.3K	15.5K
Short Term Debt	682.1K	1.1M	788.7K	14.2K	16.3K	15.5K
Other Current Liab	6.8M	39.4M	288.6K	54.1K	62.2K	59.1K
Current Deferred Revenue	10.8K	371.4K	639.4K	(14.2K)	(16.3K)	(15.5K)
Net Tangible Assets	(8.5M)	(40.4M)	9.7M	15.4M	17.7M	18.6M
Non Current Assets Total	619.8K	531.0K	438.9K	444.3K	533.8K	422.0K
Non Currrent Assets Other	163.5K	(436.6K)	(619.8K)	3.3K	3.0K	3.1K
Intangible Assets	619.8K	527.7K	435.6K	441.0K	530.6K	420.4K
Net Invested Capital	(39.0M)	10.2M	15.9M	10.3M	6.3M	6.7M
Net Working Capital	(40.4M)	9.7M	15.4M	9.9M	5.8M	6.1M
Capital Stock	771.5K	6.3K	14.1K	1.4K	1.7K	1.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Creative Historical Balance Sheet

Creative Medical Inventory

2,084.3

About Creative Balance Sheet Analysis

Creative Medical Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Common Stock Shares Outstanding

Creative Medical balance sheet Correlations

Creative Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Creative Medical balance sheet Accounts

Also Currently Popular

Additional Tools for Creative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Other Current Liab	+ 1.0	Total Current Liabilities
Other Current Liab	+ 1.0	Total Liab
Cash And Short Term Investments	+ 1.0	Total Current Assets

Cash	- 1.0	Net Debt
Other Current Assets	- 0.98	Net Receivables
Long Term Debt	- 0.97	Other Liab
Common Stock Shares Outstanding	- 0.97	Net Receivables
Cash And Short Term Investments	- 0.96	Net Debt
Net Debt	- 0.96	Total Current Assets